GRETZKY REFLECTS ON AREXVY

HEAR WAYNE GRETZKY TALK ABOUT RSV AND AREXVY

Video player requires JavaScript enabled. You can download this video here: /content/dam/cf-pharma/arexvy-ca/en_CA/Wayne_Gretzky_About_Arexvy_EN_new.mp4

Given his passion for advocating for those who may need it most, Wayne Gretzky discusses the risk that RSV could pose to older adults. He communicates that AREXVY is now available to help protect adults 60 years and older from RSV disease. Wayne Gretzky was compensated by GSK for his participation in this program.

Virus icon

WHAT IS RSV?

RSV is a common and contagious respiratory virus that affects the lungs and respiratory airways.

ABOUT RSV
Needle icon

WHAT IS AREXVY?

AREXVY is a single-dose vaccine that helps to protect adults 60 years and older from RSV disease.

WHY AREXVY?

AREXVY is a vaccine that helps to protect adults 60 years of age and older from lower lung disease caused by respiratory syncytial virus (RSV). 100% protection cannot be guaranteed. AREXVY is not indicated for the treatment of RSV and does not prevent or reduce the risk of complications. AREXVY should not be used if you are allergic to any ingredient in the vaccine. Adverse events may occur. Very common adverse events (≥10% of doses) reported in clinical trials were pain at the injection site, tiredness, headache, muscle pain (myalgia), and joint pain (arthralgia). Ask your healthcare professional if AREXVY is right for you. Full product information can be found at gsk.ca/arexvy/en. To report an adverse event, please call 1-800-387-7374.